This invention discloses a ZIF-8
nanomedicine delivery system co-loaded with
doxorubicin and siTDRKH, its preparation method, and its applications, belonging to the fields of
biomedicine and
nanomaterials technology. The
nanomedicine delivery system uses the
zeolite imidazole ester framework material ZIF-8 as a carrier. Its porous structure encapsulates the chemotherapeutic
drug doxorubicin within the framework, and
small interfering RNA targeting the TDRKH
gene is loaded onto the surface through
electrostatic adsorption. This structure exhibits high pH responsiveness: it remains stable under normal physiological conditions (pH 7.4), preventing premature
drug leakage; upon entering the slightly acidic environment of a tumor (pH 6.5) or a lysosomal environment (pH 5.0), the ZIF-8 framework immediately disintegrates, achieving targeted and synergistic release of the loaded
drug.